Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine®)
- 1 January 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (3) , 172-176
- https://doi.org/10.1016/0002-9149(89)90280-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Electrophysiology of ethmozine® (moricizine HCl) for ventricular tachycardiaThe American Journal of Cardiology, 1987
- Risk factors for the development of proarrhythmic eventsThe American Journal of Cardiology, 1987
- Proarrhythmic responses during electrophysiologic testingThe American Journal of Cardiology, 1987
- Methodology for Clinical Trials with Antiarrhythmic Drugs to Prevent Cardiac Death: US ExperienceCardiology, 1987
- Application of a frequency definition of ventricular proarrhythmiaThe American Journal of Cardiology, 1987
- Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainideJournal of the American College of Cardiology, 1986
- Analysis of the spontaneous variability of ventricular arrhythmias: Consecutive ambulatory electrocardiographic recordings of ventricular tachycardiaThe American Journal of Cardiology, 1985
- Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogramThe American Journal of Cardiology, 1984
- Secondary prevention after myocardial infarction: A review of long-term trialsProgress in Cardiovascular Diseases, 1982
- Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.Circulation, 1978